Temasek Leads $85M Series B Round In Chinese Biotech Start-Up

Gracell Biotechnologies, a Chinese biotech start-up that focuses on cellular gene therapy, has raised a US$85 million series B financing round led by Singapore’s state investment firm Temasek, according to an announcement released on Monday. China-based investment firm Kington Capital, venture capital firm King Star Capital and healthcare-focused investment platform Chengdu Miaoji, as well as […]

Temasek Leads $85M Series B Round In Chinese Biotech Start-Up comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network